story of the week
Outcomes of Adjuvant Anti–PD-1 Therapy in Patients With SLN-Positive Melanoma Who Did Not Undergo Completion Lymph Node Dissection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal for immunotherapy of cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
J Immunother Cancer 2022 Aug 01;10(8)e004417, Z Eroglu, KK Broman, JF Thompson, A Nijhuis, TJ Hieken, L Kottschade, JM Farma, M Hotz, J Deneve, M Fleming, EK Bartlett, A Sharma, L Dossett, T Hughes, DE Gyorki, J Downs, G Karakousis, Y Song, A Lee, RS Berman, A van Akkooi, E Stahlie, D Han, J Vetto, G Beasley, NE Farrow, JYC Hui, M Moncrieff, J Nobes, K Baecher, M Perez, M Lowe, DW Ollila, FA Collichio, RO Bagge, J Mattsson, HM Kroon, H Chai, J Teras, J Sun, MJ Carr, A Tandon, NA Babacan, Y Kim, M Naqvi, J Zager, NI KhushalaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.